Liver X receptors, lipids and their reproductive secrets in the male

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 8, 2011, Pages 974-981

  El Hajjaji, Fatim Zorah ^a,b,c   Oumeddour, Abdelkader ^a,b,c,d   Pommier, Aurélien J C ^a,b,c   Ouvrier, Aurélia ^a,b   Viennois, Emilie ^a,b,c   Dufour, Julie ^a,b,c   Caira, Françoise ^a,b,c   Drevet, Joël R ^a,b   Volle, David H ^a,b,c   Baron, Silvère ^a,b,c   Saez, Fabrice ^a,b   Lobaccaro, Jean Marc A ^a,b,c  

^a Faculté de Médecine   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c CRNH AUVERGNE   (France)

^d BADJI MOKHTAR UNIVERSITY   (Algeria)

Author keywords

Epididymis; Lipids; LXR; Prostate; Testis

Indexed keywords

22 HYDROXYCHOLESTEROL; 3 BETA HYDROXYSTEROID DEHYDROGENASE ISOMERASE; ALITRETINOIN; ANDROGEN; BILE ACID; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYCLIN A1; CYTOCHROME P450; CYTOCHROME P450 17; CYTOCHROME P450 SIDE CHAIN CLEAVAGE; GLUCOSE; HISTONE DEACETYLASE; LIPID; LIVER X RECEPTOR; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; MESSENGER RNA; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; OXYSTEROL; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE SHP; RETINALDEHYDE DEHYDROGENASE 2; RETINOID X RECEPTOR; STEROID; STEROIDOGENIC ACUTE REGULATORY PROTEIN; STEROL 14ALPHA DEMETHYLASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADRENAL GLAND; ANDROGEN SYNTHESIS; APOPTOSIS; ATHEROSCLEROSIS; BRAIN FUNCTION; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; DETOXIFICATION; DISEASE ASSOCIATION; ENDOCRINE DISEASE; ENZYME INDUCTION; EPIDIDYMIS; GAMETE; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNITY; KIDNEY; LIPID METABOLISM; LIVER; LIVER X RECEPTOR DEFICIENCY; LUNG; MALE INFERTILITY; NEOPLASM; NONHUMAN; OVARY; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPRODUCTION; RETINOL INTOXICATION; REVIEW; SPERMATOGENESIS; SPERMATOZOON MATURATION; STEROIDOGENESIS; SYNAPTONEMAL COMPLEX; TESTIS; TESTIS DISEASE;

ANIMALS; EPIDIDYMIS; HUMANS; LIPIDS; MALE; MICE; MICE, KNOCKOUT; ORPHAN NUCLEAR RECEPTORS; REPRODUCTION; TESTIS;

MUS;

EID: 79958272287     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.02.004     Document Type: Review

References (73)

1. Lafont R. Reverse endocrinology, or "hormones" seeking functions. Insect biochem. 1991, 21:697-721.
2. Kliewer S.A., Lehmann J.M., Willson T.M. Orphan nuclear receptors: shifting endocrinology into reverse. Science 1999, 284:757-760.
3. Willy P.J., Umesono K., Ong E.S., Evans R.M., Heyman R.A., Mangelsdorf D.J. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 1995, 9:1033-1045.
4. Shinar D.M., Endo N., Rutledge S.J., Vogel R., Rodan G.A., Schmidt A. NER, a new member of the gene family encoding the human steroid hormone nuclear receptor. Gene 1994, 147:273-276.
5. Song C., Kokontis J.M., Hiipakka R.A., Liao S. Ubiquitous receptor: a receptor that modulates gene activation by retinoic acid and thyroid hormone receptors. Proc. Natl Acad. Sci. USA 1994, 91:10809-10813.
6. Janowski B.A., Grogan M.J., Jones S.A., Wisely G.B., Kliewer S.A., Corey E.J., Mangelsdorf D.J. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc. Natl Acad. Sci. USA 1999, 96:266-271.
7. Janowski B.A., Willy P.J., Devi T.R., Falck J.R., Mangelsdorf D.J. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996, 383:728-731.
8. Hansen M., Connolly T. Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis. Curr. Opin. Investig. Drugs 2008, 9:247-255.
9. Willy P.J., Mangelsdorf D.J. Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. Genes Dev. 1997, 11:289-298.
10. Volle D.H., Lobaccaro J.M. Role of the nuclear receptors for oxysterols LXRs in steroidogenic tissues: beyond the "foie gras", the steroids and sex?. Mol. Cell. Endocrinol. 2007, 265-266:183-189.
11. Albers M., Blume B., Schlueter T., Wright M.B., Kober I., Kremoser C., Deuschle U., Koegl M. A novel principle for partial agonism of liver X receptor ligands. Competitive recruitment of activators and repressors. J. Biol. Chem. 2006, 281:4920-4930.
12. Ratni H., Wright M.B. Recent progress in liver X receptor-selective modulators. Curr. Opin. Drug Discov. Devel. 2010, 13:403-413.
13. Schroepfer G.J. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol. Rev. 2000, 80:361-554.
14. Lepesheva G.I., Waterman M.R. CYP51-the omnipotent P450. Mol. Cell. Endocrinol. 2004, 215:165-170.
15. D'Errico I., Moschetta A. Nuclear receptors, intestinal architecture and colon cancer: an intriguing link. Cell. Mol. Life Sci. 2008, 65:1523-1543.
16. Peet D.J., Turley S.D., Ma W., Janowski B.A., Lobaccaro J.M., Hammer R.E., Mangelsdorf D.J. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998, 93:693-704.
17. Alberti S., Schuster G., Parini P., Feltkamp D., Diczfalusy U., Rudling M., Angelin B., Bjorkhem I., Pettersson S., Gustafsson J.A. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J. Clin. Invest. 2001, 107:565-573.
18. Repa J.J., Turley S.D., Lobaccaro J.A., Medina J., Li L., Lustig K., Shan B., Heyman R.A., Dietschy J.M., Mangelsdorf D.J. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 2000, 289:1524-1529.
19. Wang Y., Rogers P.M., Su C., Varga G., Stayrook K.R., Burris T.P. Regulation of cholesterologenesis by the oxysterol receptor, LXRalpha. J. Biol. Chem. 2008, 283:26332-26339.
20. Barbier O., Trottier J., Kaeding J., Caron P., Verreault M. Lipid-activated transcription factors control bile acid glucuronidation. Mol. Cell. Biochem. 2009, 326:3-8.
21. Volle D.H., Repa J.J., Mazur A., Cummins C.L., Val P., Henry-Berger J., Caira F., Veyssiere G., Mangelsdorf D.J., Lobaccaro J.M. Regulation of the aldo-keto reductase gene akr1b7 by the nuclear oxysterol receptor LXRalpha (liver X receptor-alpha) in the mouse intestine: putative role of LXRs in lipid detoxification processes. Mol. Endocrinol. 2004, 18:888-898.
22. Kim T.H., Kim H., Park J.M., Im S.S., Bae J.S., Kim M.Y., Yoon H.G., Cha J.Y., Kim K.S., Ahn Y.H. Interrelationship between LXR{alpha}, SREBP-1c, PPAR{gamma} and SHP in the transcriptional regulation of glucokinase gene expression in liver. J. Biol. Chem. 2009.
23. Hong C., Tontonoz P. Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors. Curr. Opin. Genet. Dev. 2008, 18:461-467.
24. Demerjian M., Choi E.H., Man M.Q., Chang S., Elias P.M., Feingold K.R. Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis. Exp. Dermatol. 2009.
25. Koldamova R., Lefterov I. Role of LXR and ABCA1 in the pathogenesis of Alzheimer's disease-implications for a new therapeutic approach. Curr. Alzheimer Res. 2007, 4:171-178.
26. Koldamova R.P., Lefterov I.M., Staufenbiel M., Wolfe D., Huang S., Glorioso J.C., Walter M., Roth M.G., Lazo J.S. The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. J. Biol. Chem. 2005, 280:4079-4088.
27. Venkateswaran A., Repa J.J., Lobaccaro J.M., Bronson A., Mangelsdorf D.J., Edwards P.A. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J. Biol. Chem. 2000, 275:14700-14707.
28. Kennedy M.A., Venkateswaran A., Tarr P.T., Xenarios I., Kudoh J., Shimizu N., Edwards P.A. Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J. Biol. Chem. 2001, 276:39438-39447.
29. Mak P.A., Laffitte B.A., Desrumaux C., Joseph S.B., Curtiss L.K., Mangelsdorf D.J., Tontonoz P., Edwards P.A. Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta. J. Biol. Chem. 2002, 277:31900-31908.
30. Cao G., Beyer T.P., Yang X.P., Schmidt R.J., Zhang Y., Bensch W.R., Kauffman R.F., Gao H., Ryan T.P., Liang Y., Eacho P.I., Jiang X.C. Phospholipid transfer protein is regulated by liver X receptors in vivo. J. Biol. Chem. 2002, 277:39561-39565.
31. Lo Sasso G., Murzilli S., Salvatore L., D'Errico I., Petruzzelli M., Conca P., Jiang Z.Y., Calabresi L., Parini P., Moschetta A. Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab. 2010, 12:187-193.
32. Yasuda T., Grillot D., Billheimer J.T., Briand F., Delerive P., Huet S., Rader D.J. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo. Arterioscler. Thromb. Vasc. Biol. 2010, 30:781-786.
33. Cummins C.L., Volle D.H., Zhang Y., McDonald J.G., Sion B., Lefrancois-Martinez A.M., Caira F., Veyssiere G., Mangelsdorf D.J., Lobaccaro J.M. Liver X receptors regulate adrenal cholesterol balance. J. Clin. Invest. 2006, 116:1902-1912.
34. Steffensen K.R., Neo S.Y., Stulnig T.M., Vega V.B., Rahman S.S., Schuster G.U., Gustafsson J.A., Liu E.T. Genome-wide expression profiling; a panel of mouse tissues discloses novel biological functions of liver X receptors in adrenals. J. Mol. Endocrinol. 2004, 33:609-622.
35. Mascrez B., Ghyselinck N.B., Watanabe M., Annicotte J.S., Chambon P., Auwerx J., Mark M. Ligand-dependent contribution of RXRbeta to cholesterol homeostasis in Sertoli cells. EMBO Rep. 2004, 5:285-290.
36. Volle D.H., Mouzat K., Duggavathi R., Siddeek B., Dechelotte P., Sion B., Veyssiere G., Benahmed M., Lobaccaro J.M. Multiple roles of the nuclear receptors for oxysterols liver X receptor to maintain male fertility. Mol. Endocrinol. 2007, 21:1014-1027.
37. Mouzat K., Volat F., Baron S., Alves G., Pommier A.J., Volle D.H., Marceau G., DeHaze A., Dechelotte P., Duggavathi R., Caira F., Lobaccaro J.M. Absence of nuclear receptors for oxysterols liver X receptor induces ovarian hyperstimulation syndrome in mice. Endocrinology 2009, 150:3369-3375.
38. Kurioka H., Takahashi K., Kita N., Noda Y. Hemorrhagic ovarian cyst without peritoneal bleeding in a patient with ovarian hyperstimulation syndrome: case report. Chin. Med. J. (Engl) 2005, 118:1577-1581.
39. Vlahos N.F., Gregoriou O. Prevention and management of ovarian hyperstimulation syndrome. Ann. NY Acad. Sci. 2006, 1092:247-264.
40. Mouzat K., Prod'homme M., Volle D.H., Sion B., Dechelotte P., Gauthier K., Vanacker J.M., Lobaccaro J.M. Oxysterol nuclear receptor LXRbeta regulates cholesterol homeostasis and contractile function in mouse uterus. J. Biol. Chem. 2007, 282:4693-4701.
41. Robertson K.M., Schuster G.U., Steffensen K.R., Hovatta O., Meaney S., Hultenby K., Johansson L.C., Svechnikov K., Soder O., Gustafsson J.A. The liver X receptor-{beta} is essential for maintaining cholesterol homeostasis in the testis. Endocrinology 2005, 146:2519-2530.
42. Lenzi A., Picardo M., Gandini L., Dondero F. Lipids of the sperm plasma membrane: from polyunsaturated fatty acids considered as markers of sperm function to possible scavenger therapy. Hum. Reprod. Update 1996, 2:246-256.
43. Biswas N.M., Deb C. Testicular degeneration in rats during hypervitaminosis A. Endokrinologie 1965, 49:64-69.
44. Volle D.H., Duggavathi R., Magnier B.C., Houten S.M., Cummins C.L., Lobaccaro J.M., Verhoeven G., Schoonjans K., Auwerx J. The small heterodimer partner is a gonadal gatekeeper of sexual maturation in male mice. Genes Dev. 2007, 21:303-315.
45. Volle D.H., Decourteix M., Garo E., McNeilly J., Fenichel P., Auwerx J., McNeilly A.S., Schoonjans K., Benahmed M. The orphan nuclear receptor small heterodimer partner mediates male infertility induced by diethylstilbestrol in mice. J. Clin. Invest. 2009, 119:3752-3764.
46. Zhang Y., Hagedorn C.H., Wang L. Role of nuclear receptor SHP in metabolism and cancer. Biochim. Biophys. Acta 2010.
47. Chen M., Beaven S., Tontonoz P. Identification and characterization of two alternatively spliced transcript variants of human liver X receptor alpha. J. Lipid Res. 2005, 46:2570-2579.
48. Frenoux J.M., Vernet P., Volle D.H., Britan A., Saez F., Kocer A., Henry-Berger J., Mangelsdorf D.J., Lobaccaro J.M., Drevet J.R. Nuclear oxysterol receptors, LXRs, are involved in the maintenance of mouse caput epididymidis structure and functions. J. Mol. Endocrinol. 2004, 33:361-375.
49. Saez F., Chabory E., Cadet R., Vernet P., Baron S., Lobaccaro J.M., Drevet J.R. Liver X receptors and epididymal epithelium physiology. Asian J. Androl. 2007, 9:574-582.
50. Ouvrier A., Cadet R., Vernet P., Laillet B., Chardigny J.M., Lobaccaro J.M., Drevet J.R., Saez F. LXR and ABCA1 control cholesterol homeostasis in the proximal mouse epididymis in a cell-specific manner. J. Lipid Res. 2009, 50:1766-1775.
51. Bravi F., Scotti L., Bosetti C., Talamini R., Negri E., Montella M., Franceschi S., La Vecchia C. Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer. Ann. Oncol. 2006, 17:1014-1017.
52. Magura L., Blanchard R., Hope B., Beal J.R., Schwartz G.G., Sahmoun A.E. Hypercholesterolemia and prostate cancer: a hospital-based case-control study. Cancer Causes Control 2008, 19:1259-1266.
53. Watanabe M., Nakayama T., Shiraishi T., Stemmermann G.N., Yatani R. Comparative studies of prostate cancer in Japan versus the United States. A review. Urol. Oncol. 2000, 5:274-283.
54. White C. On the occurrence of crystals in tumours. J. Pathol. Bacteriol. 1909, 13:3-10.
55. Swyer G. The cholesterol content of normal and enlarged prostates. Cancer Res. 1942, 2:372-375.
56. Zhuang L., Kim J., Adam R.M., Solomon K.R., Freeman M.R. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J. Clin. Invest. 2005, 115:959-968.
57. Platz E.A., Leitzmann M.F., Visvanathan K., Rimm E.B., Stampfer M.J., Willett W.C., Giovannucci E. Statin drugs and risk of advanced prostate cancer. J. Natl Cancer Inst. 2006, 98:1819-1825.
58. Shannon J., Tewoderos S., Garzotto M., Beer T.M., Derenick R., Palma A., Farris P.E. Statins and prostate cancer risk: a case-control study. Am. J. Epidemiol. 2005, 162:318-325.
59. Murtola T.J., Visakorpi T., Lahtela J., Syvala H., Tammela T. Statins and prostate cancer prevention: where we are now, and future directions. Nat. Clin. Pract. Urol. 2008, 5:376-387.
60. Fukuchi J., Kokontis J.M., Hiipakka R.A., Chuu C.P., Liao S. Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Res. 2004, 64:7686-7689.
61. Fukuchi J., Hiipakka R.A., Kokontis J.M., Hsu S., Ko A.L., Fitzgerald M.L., Liao S. Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells. Cancer Res. 2004, 64:7682-7685.
62. Freeman M.R., Solomon K.R. Cholesterol and prostate cancer. J. Cell. Biochem. 2004, 91:54-69.
63. Yang G., Truong L.D., Timme T.L., Ren C., Wheeler T.M., Park S.H., Nasu Y., Bangma C.H., Kattan M.W., Scardino P.T., Thompson T.C. Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res. 1998, 4:1873-1880.
64. Kim J., Adam R.M., Solomon K.R., Freeman M.R. Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells. Endocrinology 2004, 145:613-619.
65. Pommier A.J., Alves G., Viennois E., Bernard S., Communal Y., Sion B., Marceau G., Damon C., Mouzat K., Caira F., Baron S., Lobaccaro J.M. Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene 2010, 29:2712-2723.
66. Viennois E., Pommier A.J.C., Mouzat K., Oumeddour A., El Hajjaji F.-Z., Dufour J., Caira F., Volle D.H., Baron S., Lobaccaro J.-M.A. Targeting Liver X Receptors in human health: deadlock or promising trail?. Expert Opin. Ther. Targets 2011, 15(2):219-232.
67. Rough J.J., Monroy M.A., Yerrum S., Daly J.M. Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells. J Ovarian Res 2010, 3:13.
68. Vedin L.L., Lewandowski S.A., Parini P., Gustafsson J.A., Steffensen K.R. The oxysterol receptor LXR inhibits proliferation of human breast cancer cells. Carcinogenesis 2009, 30:575-579.
69. Gong H., Guo P., Zhai Y., Zhou J., Uppal H., Jarzynka M.J., Song W.C., Cheng S.Y., Xie W. Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol. Endocrinol. 2007, 21:1781-1790.
70. Paolone D.R. Benign prostatic hyperplasia. Clin. Geriatr. Med. 2010, 26:223-239.
71. Roehrborn C.G. Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Med. Clin. North Am. 2011, 95:87-100.
72. Kim H.J., Andersson L.C., Bouton D., Warner M., Gustafsson J.A. Stromal growth and epithelial cell proliferation in ventral prostates of liver X receptor knockout mice. Proc. Natl Acad. Sci. USA 2009, 106:558-563.
73. Junquiera L.C., Carniero J., Kelley R.O. Basic Histology 1989, Appleton and Lange, Norwalk, CT. 6th ed.